Pier Capital, LLC Revance Therapeutics, Inc. Transaction History

Pier Capital, LLC

  • $670 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$12.46 - $27.87 $2.07 Million - $4.62 Million
-165,913 Closed
0 $0
Q3 2021

Nov 10, 2021
SELL
$25.78 - $33.21 $113,509 - $146,223
-4,403 Reduced 2.59%
165,913 $4.62 Million
Q2 2021

Aug 12, 2021
BUY
$26.8 - $31.84 $4.56 Million - $5.42 Million
170,316 New
170,316 $5.05 Million

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email